Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Decoding 18 Analyst Evaluations For Boston Scientific is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Demystifying Boston Scientific: Insights From 9 Analyst Reviews
Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target; Steven Lichtman: Oppenheimer: Raises: Outperform: $125.00: $118.00: Danielle Antalffy: UBS: Raise ... Read More
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.72 per share, indicating an increase of 16.1% compared to the year-ago period. Analysts forecast ... Read More
Boston Scientific lifts annual profit forecast, sees smaller tariff impact
July 23 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed its expectation for ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus